Oxygen Health Communications will target pharmaceutical and biotech companies.
‘Pharmaceutical and biotech companies are facing a unique set of challenges at this time,' said Oakley. ‘In addition, the health communications environment continues to evolve rapidly. I want to help the industry develop a more thorough understanding of the new environment, working more closely with its key stakeholders, to help ensure future success.'
To help achieve this, Oxygen has developed a range of new proprietary stakeholder analysis tools.
In addition to working with industry clients, Oxygen aims to work on projects with charities and non-profit organisations in the health arena.
Oakley also previously worked at Fleishman-Hillard, Porter Novelli, Chandler Chicco Agency and Edelman.